Birch Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$160K Buy
138
+35
+34% +$41.3K 0.07% 60
2026
Q2
$124K Buy
+103
New +$105K 0.06% 63
2026
Q1
– Sell
-59
Closed -$63.4K – 80
2025
Q4
$63.4K Buy
+59
New +$56.4K 0.03% 70

Other funds holding LLY

Birch Capital Management's LLY Position: Q3 2026 in Review

Birch Capital Management increased its Eli Lilly (LLY) stake by 34% in Q3 2026, buying an estimated $41.3K and bringing the position to 138 shares worth $160K. The position accounts for 0.07% of the portfolio, ranked #60.

Birch Capital Management first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 3,033 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Birch Capital Management held 138 shares of Eli Lilly worth $160K as of Q3 2026.
  • Birch Capital Management bought 35 Eli Lilly shares in Q3 2026, an estimated $41.3K.
  • Eli Lilly made up 0.07% of Birch Capital Management's portfolio in Q3 2026, its #60 holding.
  • Birch Capital Management first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 3,033 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Birch Capital Management's 13F filing for Q3 2026, filed 27 Oct 2026.